Title |
Multiple myeloma: five-year experience at a University Hospital
|
---|---|
Published in |
Einstein (São Paulo), June 2011
|
DOI | 10.1590/s1679-45082011ao2006 |
Pubmed ID | |
Authors |
Juliana Todaro, Jandey Bigonha, Davimar Miranda Maciel Borducchi, Leandro Luongo Matos, Damila Cristina Trufelli, Suzane Martines Alves de Sales, Marina Rampazzo Del Valhe Shiroma, Auro del Giglio |
Abstract |
To present a descriptive analysis of patients diagnosed with multiple myeloma, correlating it with mortality. A retrospective study that analyzed consecutive patients diagnosed with multiple myeloma under follow-up at the Faculdade de Medicina do ABC from 2006 to 2010. The median age was 58.5 years. Anemia was observed upon diagnosis in 87% of patients, hypercalcemia in 38%, and creatinine levels higher than 2 mg/dL in 19%. M protein was detected in 85.7%. The five-year survival rate was 74.6%. Multivariate analysis showed statistical significance for Durie-Salmon staging (p = 0.037). The International Staging System and immunoglobulin type did not correlate significantly with survival of the group. This set of cases from a tertiary public healthcare service reflect the approach of multiple myeloma in a predominantly young population with advanced clinical staging, with results comparable to those of the literature. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 20 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 9 | 45% |
Unspecified | 1 | 5% |
Other | 1 | 5% |
Librarian | 1 | 5% |
Student > Doctoral Student | 1 | 5% |
Other | 1 | 5% |
Unknown | 6 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 40% |
Immunology and Microbiology | 2 | 10% |
Biochemistry, Genetics and Molecular Biology | 1 | 5% |
Unspecified | 1 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Other | 1 | 5% |
Unknown | 6 | 30% |